
Hera Health Solutions
Unlocking The True Potential Of The World's Therapeutics
Memphis, United States · Founded 2022 · $380K raised
- Headquarters
- Memphis, Tennessee
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- herahealthsolutions.com
- Total Funding
- $380K
- Last Round
- $280K GrantMay 2023
- Rounds
- 3
About
Hera Health Solutions is a biotechnology company specializing in the research, development, and commercialization of a proprietary nanotechnology-enabled drug delivery platform. The platform is designed to rapidly reformulate existing active pharmaceutical ingredients (APIs) into upgraded, long-acting, and customizable release-profile therapeutics. Key capabilities include FDA and GMP-compliant manufacturing, product and API optimization, toxicity mitigation, and biodegradable patient-optimized formulations. The company has announced global pharmaceutical contract partnerships and its technology has been featured in Entrepreneur Magazine.
Summary
Hera Health Solutions is a Healthcare company based in Memphis, United States, founded in 2022. It has raised $380K in total across 3 rounds, most recently a $280K Grant round in May 2023. Investors include Innova Capital.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2023
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...